Background: Assessing pruritus severity is difficult because of its subjective nature. A questionnaire that takes into account how the symptom is perceived by the patient may provide a more accurate representation of the pruritus. However, recently developed questionnaires do not specifically quantify severity of the symptom.
Objectives: To develop a self-report questionnaire to measure pruritus severity and to provide initial evidence of its validity and reliability.
Methods: We modified a previously developed interview for the characterization and evaluation of pruritus, which was completed along with the RAND-36 Health Status Inventory and Dermatology Life Quality Index by patients with psoriasis-associated pruritus. Exploratory factor analysis, studies of internal consistency, and correlation analyses with health-related quality of life scores were used to help determine which components of the modified pruritus interview to include in the new questionnaire, the Itch Severity Scale (ISS). The ISS was then assessed for construct validity, internal consistency reliability and test-retest reliability.
Results: Seven of the initial 11 components of the modified pruritus interview were included in the ISS. ISS scores correlated moderately with physical (r=-0 x 483) and mental (r=-0 x 492) health composite scores of the RAND-36 and strongly with Dermatology Life Quality Index scores (r=0 x 628), evidence of construct validity. It had an internal consistency reliability of 0 x 80 and a test-retest reliability of 0 x 95.
Conclusions: Based on this preliminary evidence of validity and reliability, this new seven-item ISS may be useful in comparing pruritus severity among different disease populations or in assessing pruritus treatment effectiveness.
Kwon S, Visco AG, Fitzgerald MP, Ye W, Whitehead WE; Pelvic Floor Disorders Network (PFDN). Kwon S, et al. Dis Colon Rectum. 2005 Feb;48(2):323-31; discussion 331-4. doi: 10.1007/s10350-004-0899-y. Dis Colon Rectum. 2005. PMID: 15616750
Gurel MS, Yanik M, Simsek Z, Kati M, Karaman A. Gurel MS, et al. Int J Dermatol. 2005 Nov;44(11):933-8. doi: 10.1111/j.1365-4632.2004.02225.x. Int J Dermatol. 2005. PMID: 16336527
Basra MK, Sue-Ho R, Finlay AY. Basra MK, et al. Br J Dermatol. 2007 Mar;156(3):528-38. doi: 10.1111/j.1365-2133.2006.07617.x. Br J Dermatol. 2007. PMID: 17300244
Halvorsen JG. Halvorsen JG. Fam Med. 1990 Nov-Dec;22(6):478-84. Fam Med. 1990. PMID: 2262112 Review.Birken CS, Parkin PC, Macarthur C. Birken CS, et al. J Clin Epidemiol. 2004 Nov;57(11):1177-81. doi: 10.1016/j.jclinepi.2004.02.016. J Clin Epidemiol. 2004. PMID: 15567635 Review.
Lax SJ, Van Vogt E, Candy B, Steele L, Reynolds C, Stuart B, Parker R, Axon E, Roberts A, Doyle M, Chu DK, Futamura M, Santer M, Williams HC, Cro S, Drucker AM, Boyle RJ. Lax SJ, et al. Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015064. doi: 10.1002/14651858.CD015064.pub2. Cochrane Database Syst Rev. 2024. PMID: 39105474 Free PMC article. Review.
Esteve-Simó V, Perez-Morales R, Buades-Fuster JM, Arenas Jimenez MD, Areste-Fosalba N, Alcalde Bezhold G, Blanco Santos A, Sanchez Álvarez E, Sanchez Villanueva R, Molina P, Ojeda R, Prieto-Velasco M, Goicoechea M. Esteve-Simó V, et al. J Clin Med. 2023 Jul 5;12(13):4505. doi: 10.3390/jcm12134505. J Clin Med. 2023. PMID: 37445539 Free PMC article. Review.
Kennedy DL, Chism-Balangue T, Furniss D. Kennedy DL, et al. BMC Musculoskelet Disord. 2023 Mar 31;24(1):249. doi: 10.1186/s12891-023-06296-y. BMC Musculoskelet Disord. 2023. PMID: 37004025 Free PMC article. Review.
Jha CM, Dastoor HD, Gopalakrishnan N, Holt SG. Jha CM, et al. Int J Nephrol Renovasc Dis. 2022 Dec 6;15:335-352. doi: 10.2147/IJNRD.S294147. eCollection 2022. Int J Nephrol Renovasc Dis. 2022. PMID: 36510564 Free PMC article. Review.
Ryoo JH, Lee SH, Ha DL, Park KD, Rho J, Park GH, Kim BS, Li K, Park CO, Kim HO, Kim HS, Jang MS, Lee DH, Lee YW, Kim DW, Jang YH, Kim SJ. Ryoo JH, et al. Acta Derm Venereol. 2022 Nov 24;102:adv00819. doi: 10.2340/actadv.v102.2527. Acta Derm Venereol. 2022. PMID: 36420696 Free PMC article.